Fifth Third Bancorp
PBE icon

Fifth Third Bancorp’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Fifth Third Bancorp’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.9K Buy
+378
New +$30.6K ﹤0.01% 3380
2014
Q1 		– Sell
-500
Closed -$19K – 2353
2013
Q4 		$19K Hold
500
– – ﹤0.01% 1682
2013
Q3 		$18K Buy
+500
New +$16.6K ﹤0.01% 1708

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Fifth Third Bancorp's PBE Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q1 2026: 378 shares worth $29.9K. The stake represents ﹤0.01% of the portfolio and ranks #3380 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in PBE as recently as Q4 2013.

Fifth Third Bancorp first reported a position in PBE in Q3 2013 and has held it in 3 quarters since. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

  • Fifth Third Bancorp held 378 shares of Invesco Biotechnology & Genome ETF worth $29.9K as of Q1 2026.
  • Invesco Biotechnology & Genome ETF was a new Fifth Third Bancorp position in Q1 2026.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3380 holding.
  • Fifth Third Bancorp first reported a position in Invesco Biotechnology & Genome ETF in Q3 2013 and has held it in 3 quarters since.
  • 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.